Latest News in the pharma Industry

All

Bristol Myers Squibb disappointed with failed late-stage combo drug trial

Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial

9 Mar 2020

Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.

Read more 
Nanoform and Orion collaborate on 'nanoformed' APIs

Nanoform and Orion collaborate on 'nanoformed' APIs

9 Mar 2020

Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.

Read more 
Bora Pharmaceuticals to buy GSK's Mississauga-based manufacturing facility

Bora Pharmaceuticals to buy GSK's Mississauga-based manufacturing facility

9 Mar 2020

CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide.

Read more 
Systech International to be Acquired by Dover Corporation

Systech International to be Acquired by Dover Corporation

4 Mar 2020

Systech International (“Systech”) announced today that it has entered into a definitive agreement to be acquired by Dover Corporation.

Read more 
Sai Life Sciences SCM shines with awards in Supply Risk and Supplier Relationship Management

Sai Life Sciences SCM shines with awards in Supply Risk and Supplier Relationship Management

4 Mar 2020

Sai Life Sciences won two awards at the recently concluded 2nd SCMPro India Procurement Leadership Forum & Awards 2020, in the categories of Supply Risk Management and Supplier Relationship Management.

Read more 
Sai Life Sciences receives ISO 14001:2015 and ISO 45001:2018 certification

Sai Life Sciences receives ISO 14001:2015 and ISO 45001:2018 certification

4 Mar 2020

Sai Life Sciences received the ISO 14001:2015 (Environment management system) and ISO 45001:2018 (Occupational health and safety management system) certification for its R&D centre (Unit II), Manufacturing facility (Unit IV) and Corporate office.

Read more 
FLAVOXALE® -  a unique ingredient from Disproquima

FLAVOXALE® - a unique ingredient from Disproquima

3 Mar 2020

FLAVOXALE® is a unique ingredient derived from the combination of an exclusive propolis extract (M.E.D. propolis), manuka honey and manuka essential oil.

Read more 
Samsung Biologics agrees development contract with STCube for anti-cancer candidate

Samsung Biologics agrees development contract with STCube for anti-cancer candidate

3 Mar 2020

Samsung Biologics has signed a development and manufacturing service agreement with local biotech firm, STCube, for the latter’s anti-cancer drug candidate, STT-003, the South Korean CDMO said Tuesday.

Read more 
Thermo Fisher Scientific to acquire Qiagen

Thermo Fisher Scientific to acquire Qiagen

3 Mar 2020

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

Read more 
Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven

Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven

3 Mar 2020

Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.

Read more 
MindMed becomes world's first psychedelic pharma company to go public

MindMed becomes world's first psychedelic pharma company to go public

3 Mar 2020

The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Read more 
Jim Miller joins C2 Pharma advisory board

Jim Miller joins C2 Pharma advisory board

3 Mar 2020

Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.

Read more